v3.23.1
Equity Method Investments - Summarized Statement of Operations (Details) - USD ($)
$ in Millions
 7 Months Ended 12 Months Ended
Aug. 04, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Equity Method Investment, Summarized Financial Information [Abstract]        
Revenue   $ 443.8 $ 245.3 $ 307.5
Operating expenses   (549.9) (334.8) (514.5)
Net income (loss)   (292.8) (193.0) (317.6)
Perfomex        
Equity Method Investment, Summarized Financial Information [Abstract]        
Revenue   157.9 110.1 134.4
Operating expenses   (154.6) (105.0) (121.4)
Net income (loss)   0.0 1.0 11.8
Perfomex II        
Equity Method Investment, Summarized Financial Information [Abstract]        
Revenue   83.4 61.9 45.2
Operating expenses   (81.7) (54.2) (45.6)
Net income (loss)   $ 2.4 $ 5.1 0.2
Opex        
Equity Method Investment, Summarized Financial Information [Abstract]        
Revenue $ 199.4     263.8
Operating expenses (167.7)     (223.9)
Net income (loss) 30.9     10.7
Akal        
Equity Method Investment, Summarized Financial Information [Abstract]        
Revenue 102.2     122.4
Operating expenses (107.1)     (123.6)
Net income (loss) $ (1.7)     $ (3.4)